Lucid Diagnostics (LUCD) Interest Coverage Ratio (2020 - 2026)
Lucid Diagnostics (LUCD) posted Interest Coverage Ratio of 7.08 for Q1 2026, up 48.12% on a QoQ basis from 13.66 in Q4 2025, and down 12.9% year-over-year from 8.13 in Q1 2025.
Lucid Diagnostics (LUCD) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Lucid Diagnostics' Interest Coverage Ratio history runs 7 years deep, the most recent figure standing at 7.08 for Q1 2026.
- Quarterly Interest Coverage Ratio fell 12.9% year-over-year to 7.08 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 28.81 (down 20.08% YoY) and the FY2025 annual result came in at 0.75, up 14.28% from the prior year.
- Interest Coverage Ratio was 7.08 for Q1 2026 at Lucid Diagnostics, up from 13.66 in the prior quarter.
- Across five years, Interest Coverage Ratio topped out at 4.61 in Q2 2025 and bottomed at 1767.86 in Q4 2024.
- A 5-year average of 134.11 and a median of 22.82 in 2023 frame the typical range for Interest Coverage Ratio.
- Annual changes were most pronounced in 2023 — Interest Coverage Ratio sank 385.82% — and 2025, when it jumped 99.23%.
- Lucid Diagnostics' Interest Coverage Ratio stood at 57.6 in 2022, then surged by 44.32% to 32.07 in 2023, then slumped by 5412.64% to 1767.86 in 2024, then soared by 99.23% to 13.66 in 2025, then jumped by 48.12% to 7.08 in 2026.
- Business Quant data shows LUCD's Interest Coverage Ratio at 7.08 in Q1 2026, 13.66 in Q4 2025, and 10.91 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 82.35 |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -2.90 |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 5.36 |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Lucid Diagnostics | 133.09 Mn | 105.22 Mn | -325,000.00 | -7.08 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.08 |
| Dec 31, 2025 | -13.66 |
| Sep 30, 2025 | -10.91 |
| Jun 30, 2025 | -4.61 |
| Mar 31, 2025 | -6.27 |
| Dec 31, 2024 | -1,767.86 |
| Sep 30, 2024 | -32.21 |
| Jun 30, 2024 | -27.57 |
| Mar 31, 2024 | -9.92 |
| Sep 30, 2023 | -32.07 |
| Jun 30, 2023 | -18.07 |
| Mar 31, 2023 | -50.24 |
| Dec 31, 2022 | -57.60 |
| Sep 30, 2022 | -6.60 |
| Jun 30, 2022 | -46.29 |
| Mar 31, 2022 | -54.78 |
| Dec 31, 2021 | -172.94 |
| Sep 30, 2021 | -14.56 |
| Jun 30, 2021 | -40.93 |
| Dec 31, 2020 | -0.57 |